Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by STOCKMAN70on Nov 11, 2016 4:06pm

125 Views

Post# 25451581

RE:From the Q3 conference call

Great post!

i think this is going to be a well diversified company once the Apicore purchase goes through mid 2017. Right now they have excellent cash flows from operations and the sales growth rate will be increasing wth the bolus vial. STEMI approval would be a huge bonus but even without it this is becoming one of Canada's best companies!

stockman
long DXD.V, HNR, MPH.V

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading